Tracer Biotechnologies is a biotechnology company that offers monitoring services for oncology patients.
Tracer Biotechnologies has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Tracer Biotechnologies's investors include Caffeinated Capital, EXOR N.V., Impatient Ventures, Pareto Holdings, Great Oaks Venture Capital.
Tracer Biotechnologies is headquartered in New York, United States.
Tracer Biotechnologies is a biotechnology company that offers monitoring services for oncology patients.
Tracer Biotechnologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tracer Biotechnologies — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/tracer-biotechnologies. Accessed July 19, 2026.
VCBacked. (2024). Tracer Biotechnologies — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tracer-biotechnologies
{{cite web |title=Tracer Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/tracer-biotechnologies |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated